A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
A Premier survey identifies which waivers and flexibilities hospitals, health systems and other providers are still leveraging and their readiness to unwind from the PHE.
Premier submitted comments to the Patent and Trade Office and FDA on ways to ensure the patent system does not lead to increased pharmaceutical costs.
Watch this on-demand webinar to hear from Premier staff as they discuss the various new requirements and policies for providers, as well as what trends...
Premier applauds FDA for addressing the inequities that exists for individuals who identify as LGBTQ+ and their eligibility to donate blood.
Premier provides input on the Administration's proposal to modernize the 40-year-old law governing providers' access to their patients' data on substance use.
As the 118th Congress commences, government leaders have an opportunity to coalesce around meaningful healthcare policy solutions.
Watch this on-demand webinar to learn more about these proposed regulatory changes and how they could impact your organization.
Premier responds to healthcare provisions in the FY 2023 omnibus funding package released by Congress.
Premier urges FDA . Premier urges the FDA to address three critical areas to ensure success in reducing disparities for medical devices.
Premier responds to CMS proposed requirements on Medicare Advantage around prior authorization, health equity and behavioral health.
Premier applauds the introduction of legislation to extend Medicare bonuses for participation in Advanced Alternative Payment Models.
Premier is pleased that CMS proposes transparency requirements that will increase plan accountability for rampant prior authorization delays and denials.